About Eyenuk
Eyenuk is a company based in Los Angeles (United States) founded in 2010 by Kaushal Solanki. Eyenuk has raised $38.05 million across 17 funding rounds from investors including NIH, HHS and AXA Investment Managers. Eyenuk offers products and services including EyeArt, Eyescreen Service, and Retinal Cameras. Eyenuk operates in a competitive market with competitors including AIdoc, AI Medical Service, eCential Robotics, Lantheus and Vista.ai, among others.
- Headquarter Los Angeles, United States
- Founders Kaushal Solanki
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Eyenuk, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$38.05 M (USD)
in 17 rounds
-
Latest Funding Round
$26 M (USD), Series A
Aug 23, 2022
-
Investors
NIH
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Eyenuk
Eyenuk offers a comprehensive portfolio of products and services, including EyeArt, Eyescreen Service, and Retinal Cameras.
Autonomous AI tool for detecting diabetic retinopathy from retinal images
Provides retinal image analysis for various eye diseases
Hardware for capturing retinal images in clinical settings
People of Eyenuk
Unlock access to complete
Operations Team
1 people
Product Management Team
1 people
Strategic Team
1 people
Clinical Team
1 people
Unlock access to complete
Funding Insights of Eyenuk
Eyenuk has successfully raised a total of $38.05M across 17 strategic funding rounds. The most recent funding activity was a Series A round of $26 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Eyenuk
Eyenuk has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and AXA Investment Managers.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified alternative assets are managed through investment strategies.
|
Locked | Locked | Locked | |
|
Venture capital investments are focused on health technology breakthroughs.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Eyenuk
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Eyenuk
Investment portfolio details for Eyenuk
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Eyenuk
Detailed financials for Eyenuk
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Eyenuk Comparisons
Peer comparison for Eyenuk
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Eyenuk
Eyenuk operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AIdoc, AI Medical Service, eCential Robotics, Lantheus and Vista.ai, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based single-screen system is provided to streamline medical imaging.
|
|
| Locked | Locked | Locked |
Provider of AI-based solution for diagnosis of cancer related lesions
|
|
| Locked | Locked | Locked |
Robotic surgery platform for bone procedures is developed.
|
|
| Locked | Locked | Locked |
Developer of diagnostic imaging agents and targeted therapeutics
|
|
| Locked | Locked | Locked |
AI-guided software is utilized to automate MRI exams for clinicians.
|
|
| Locked | Locked | Locked |
Provider of AI-based skin cancer monitoring and detecting device for patients and doctors
|
Detailed competitors of Eyenuk
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Eyenuk
Complete news archive for Eyenuk
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eyenuk
Eyenuk was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Eyenuk is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Gaurav Agarwal is the current CEO of Eyenuk.
Eyenuk is a funded company, having raised a total of $38.05M across 17 funding rounds to date.
Eyenuk was established in 2010 in Los Angeles, United States, within the health technology sector focused on ophthalmology. Automated analysis of retinal images is provided through machine learning to detect diabetic retinopathy lesions in fundus photographs via the EyeArt platform. Progression tracking is enabled by EyeMark, while EyeSeeAMD supports diagnosis of age-related macular degeneration. Mobile screening is facilitated by EyeApp, which integrates smartphones with compact imaging devices for on-site assessments.
Eyenuk's top competitors include AIdoc, eCential Robotics and Vista.ai.
Eyenuk offers EyeArt, Eyescreen Service, and Retinal Cameras.
Eyenuk has 7 investors. Key investors include NIH, HHS, AXA Investment Managers, T&W Medical A/S, and Kendall Capital Partners.